India Glycols Limited (INDIAGLYCO) AI Stock Analysis

• Market Cap: ₹26.52B
• Dividend Yield: 0.47%
• Average Volume (3M): 7.46K
• Price to Earnings (P/E): 21.8
• Beta (1Y): 1.32
• Revenue Growth: 7.46%
• EPS Growth: 33.79%
• Country: IN
• Employees: 1,326
• Sector: Basic Materials
• Sector Strength: 60
• Industry: Chemicals
• EPS (TTM): 11.83
• Shares Outstanding: 30,961,500
• 10 Day Avg. Volume: 6,366
• 30 Day Avg. Volume: 7,458
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹874.00
• Price Target Upside: 2.03% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 54 Neutral
• Price Target: ₹874.00 ▲(2.03% Upside)

India Glycols Limited's overall stock score reflects a cautious outlook. The most significant factor is the mixed financial performance, with strong revenue growth overshadowed by declining profit margins and increased leverage. Technical analysis indicates bearish momentum, adding to the cautious sentiment. Valuation is moderate, but the low dividend yield may deter income investors. The absence of earnings call and corporate events data limits further insights.

India Glycols Limited Business Overview & Revenue Model

Company Description

India Glycols Limited (INDIAGLYCO) is a leading manufacturer and supplier of green technology-based chemical products, specializing in glycols, ethoxylates, and performance chemicals. The company operates in sectors such as industrial chemicals, natural gums, and spirits, offering a diverse portfolio of eco-friendly products. It is recognized for its commitment to sustainability and innovation, providing solutions that cater to various industries including automotive, textile, personal care, and pharmaceuticals.

How the Company Makes Money

India Glycols Limited generates revenue primarily through the production and sale of chemical products such as glycols, ethoxylates, and performance chemicals. The company leverages its robust manufacturing capabilities and technological expertise to serve a wide range of industries. Glycols, used in automotive antifreeze and coolant applications, and ethoxylates, utilized in detergents and personal care products, are significant contributors to its revenue. Furthermore, the company has a substantial presence in the spirits sector, producing and selling alcohol-based products, which is a vital revenue stream. Strategic partnerships and a strong focus on sustainable and innovative solutions also play a crucial role in its financial performance, enhancing its market reach and customer base.

India Glycols Limited Financial Statement Overview

Summary

India Glycols Limited shows strong revenue growth and effective equity utilization. However, declining profit margins, increased leverage, and negative free cash flow highlight significant areas of concern that need addressing to ensure financial sustainability.

Income Statement

India Glycols Limited shows a mixed performance in its income statement. The gross profit margin is healthy at approximately 26.5% for 2025, indicating efficient cost management. However, the net profit margin saw a decline from 5.3% in 2024 to 6.1% in 2025, showing moderate profitability. Revenue growth was strong in 2024 at 23.3%, but slowed down to 15.3% in 2025. EBIT margin is at 6.5% for 2025, indicating some operational efficiency but room for improvement. Overall, while there are areas of strength, such as revenue growth, declining margins present a challenge.

Balance Sheet

The balance sheet reveals a stable yet cautious financial position. The debt-to-equity ratio increased to 0.84 in 2025, suggesting higher leverage which could heighten financial risk. Return on Equity (ROE) improved to 10.2%, reflecting better utilization of equity. The equity ratio is stable at 36.5%, indicating a reasonable proportion of assets financed by equity. While the company maintains a solid equity base, increasing debt levels pose a potential risk to financial stability.

Cash Flow

Cash flow analysis indicates some challenges, particularly in free cash flow generation which remained negative at -3.98 billion in 2025. The operating cash flow to net income ratio stands at 1.57, which is healthy, suggesting good cash conversion from profits. However, the free cash flow to net income ratio is negative due to high capital expenditures, indicating potential future cash flow constraints. Improving free cash flow generation should be a priority to bolster financial flexibility.

Breakdown	Mar 2025	Mar 2023	Mar 2024	Mar 2022	Mar 2021
Income Statement
Total Revenue	37.68B	26.51B	32.69B	28.13B	22.48B
Gross Profit	9.99B	10.69B	10.55B	8.45B	7.06B
EBITDA	5.11B	3.47B	4.28B	4.98B	2.86B
Net Income	2.31B	1.25B	1.73B	3.40B	1.32B
Balance Sheet
Total Assets	61.76B	48.58B	56.17B	46.31B	41.19B
Cash, Cash Equivalents and Short-Term Investments	774.40M	2.83B	746.42M	430.66M	396.11M
Total Debt	18.92B	11.12B	13.48B	10.42B	11.37B
Total Liabilities	39.20B	29.57B	35.66B	28.58B	29.51B
Stockholders Equity	22.56B	19.01B	20.51B	17.92B	11.69B
Cash Flow
Free Cash Flow	-3.98B	-1.13B	-1.14B	-2.64B	-115.54M
Operating Cash Flow	3.62B	3.26B	4.39B	1.16B	1.37B
Investing Cash Flow	-7.36B	-3.30B	-5.03B	764.47M	-1.48B
Financing Cash Flow	3.54B	-5.10M	899.12M	-1.89B	107.45M

India Glycols Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 856.65
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDIAGLYCO, the sentiment is Negative. The current price of 856.65 is below the 20-day moving average (MA) of 882.21, below the 50-day MA of 943.00, and above the 200-day MA of 730.66, indicating a neutral trend. The MACD of -23.33 indicates Negative momentum. The RSI at 39.81 is Neutral, neither overbought nor oversold. The STOCH value of 45.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INDIAGLYCO.

India Glycols Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SUNFLAG	64 Neutral	₹53.39B	27.13		―	3.63%	35.19%
GNFC	61 Neutral	₹73.87B	13.15		3.28%	-9.97%	9.60%
Sector *	61 Neutral	$10.08B	5.96	1.53%	3.00%	3.04%	-41.02%
GUJALKALI	56 Neutral	₹41.14B	―		2.47%	7.00%	72.50%
LXCHEM	55 Neutral	₹50.54B	50.23		0.27%	3.62%	-14.41%
INDIAGLYCO	54 Neutral	₹26.52B	21.76		0.47%	7.46%	33.79%
CAMLINFINE	43 Neutral	₹39.87B	―		―	8.06%	19.90%